CCRM
Melissa Perea is an Associate Scientist II at CCRM, having joined in April 2021 after previously holding the title of Associate Scientist I and overseeing laboratory operations. Prior experience includes roles at the University of British Columbia, where responsibilities varied from front desk representation to conducting research in forensic psychology and neuroscience. Notably, Melissa successfully recruited over 100 participants for psychology studies and assisted in biochemical laboratory procedures. Educational qualifications include a Bachelor of Science in Biochemistry and Molecular Biology and a Bachelor's degree in Psychology, both from the University of British Columbia, complemented by a multicultural preparatory education from Tecnológico de Monterrey.
CCRM
1 followers
Regenerative Medicine (RM), which aims to harness the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs, has the promise to treat, manage and perhaps cure some of the most devastating and costly diseases in the world today. Many new and potentially life-changing RM-based treatments never reach patients because they are not successfully moved from the laboratory to a stage where they can be used in medicine. In order to fulfill RM’s promise to treat the many diseases affecting our population, a world-renowned group of stem cell scientists and engineers have come together to form CCRM, a leader in developing and commercializing regenerative medicine and cell therapy technologies. CCRM formally launched on June 14, 2011. CCRM supports the development and commercialization of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy.